Show simple item record

EAE mediated by a non-IFN-Γ/non-IL-17 pathway

dc.contributor.authorKroenke, Mark A.en_US
dc.contributor.authorChensue, Stephen W.en_US
dc.contributor.authorSegal, Benjamin M.en_US
dc.date.accessioned2010-09-02T15:21:44Z
dc.date.available2011-03-01T16:26:45Zen_US
dc.date.issued2010-08en_US
dc.identifier.citationKroenke, Mark A.; Chensue, Stephen W.; Segal, Benjamin M. (2010). "EAE mediated by a non-IFN-Γ/non-IL-17 pathway." European Journal of Immunology 40(8): 2340-2348. <http://hdl.handle.net/2027.42/77956>en_US
dc.identifier.issn0014-2980en_US
dc.identifier.issn1521-4141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/77956
dc.description.abstractPrevious studies have shown that EAE can be elicited by the adoptive transfer of either IFN-Γ-producing (Th1) or IL-17-producing (Th17) myelin-specific CD4 + T-cell lines. Paradoxically, mice deficient in either IFN-Γ or IL-17 remain susceptible to EAE following immunization with myelin antigens in CFA. These observations raise questions about the redundancy of IFN-Γ and IL-17 in autoimmune demyelinating disease mediated by a diverse, polyclonal population of autoreactive T cells. In this study, we show that an atypical form of EAE, induced in C57BL/6 mice by the adoptive transfer of IFN-Γ-deficient effector T cells, required IL-17 signaling for the development of brainstem infiltrates. In contrast, classical EAE, characterized by predominant spinal cord inflammation, occurred in the combined absence of IFN-Γ and IL-17 signaling, but was dependent on GM-CSF and CXCR2. Our findings contribute to a growing body of data, indicating that individual cytokines vary in their importance across different models of CNS autoimmunity.en_US
dc.format.extent435625 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWILEY-VCH Verlagen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherMicrobiology and Immunologyen_US
dc.titleEAE mediated by a non-IFN-Γ/non-IL-17 pathwayen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumHoltom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan, Ann Arbor, MI, USA ; Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USAen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA ; Department of Pathology and Laboratory Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumHoltom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan, Ann Arbor, MI, USA ; Department of Neurology, 4013 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA Fax:+1-734-615-7300en_US
dc.identifier.pmid20540117en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/77956/1/2340_ftp.pdf
dc.identifier.doi10.1002/eji.201040489en_US
dc.identifier.sourceEuropean Journal of Immunologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.